HALO to support EPSRC grant EP/K020196/1 on Point-of-Care High Accuracy Fracture Risk Prediction
Date: 19 September 2013
HALO X-ray will provide access to core IP for the detection of osteoporosis as part of an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction (goo.gl/BZ46qX).
HALO X-ray Technologies Ltd is to support an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction. HALO will provide access to IP for the purposes of developing new techniques and systems for the detection of osteo diseases such as osteoporosis. HALO will support the academic teams in the application of core IP in this field and in tandem develop techniques for commercially-viable medical systems, for early exploitation as OEM components or standalone point-of-care equipment.
This EPSRC grant demonstrates the continued commitment from UK government to new technologies in the medical field and is a key component for HALO to achieve early adoption and business success in this sector.
HALO CEO, Simon Godber, stated “We look forward to working with the academic teams in developing new techniques for detecting bone quality. Medical systems are a major part of our long-term business strategy and we are keen to work with partners to develop HALO IP in a form suitable for commercial exploitation. We see this work as an important step in developing our business solutions for the medical field”.
HALO X-ray Technologies Ltd is pioneering the development of advanced, real-time, X-ray diffraction techniques and systems in aviation security, medical systems and industrial process control.